Baruch Spivak

3.0k total citations
76 papers, 1.8k citations indexed

About

Baruch Spivak is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Baruch Spivak has authored 76 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Psychiatry and Mental health, 24 papers in Clinical Psychology and 10 papers in Pharmacology. Recurrent topics in Baruch Spivak's work include Schizophrenia research and treatment (19 papers), Obsessive-Compulsive Spectrum Disorders (9 papers) and Tryptophan and brain disorders (9 papers). Baruch Spivak is often cited by papers focused on Schizophrenia research and treatment (19 papers), Obsessive-Compulsive Spectrum Disorders (9 papers) and Tryptophan and brain disorders (9 papers). Baruch Spivak collaborates with scholars based in Israel, United States and Norway. Baruch Spivak's co-authors include Abraham Weizman, Roberto Mester, Rael D. Strous, Moshe Kotler, Rachel Maayan, Efrat Aharonovich, Ilya Reznik, Deborah S. Hasin, Tamar Mozes and Dvora Shmulewitz and has published in prestigious journals such as Biological Psychiatry, The British Journal of Psychiatry and Psychological Medicine.

In The Last Decade

Baruch Spivak

73 papers receiving 1.7k citations

Peers

Baruch Spivak
Nadja P. Marić Serbia
Roberto Mester Israel
Sook-Haeng Joe South Korea
In‐Kwa Jung South Korea
Lefteris Lykouras Greece
I Hui Lee Taiwan
Olli Kampman Finland
Ömer Aydemır Türkiye
Clemente García‐Rizo Spain
Jonna Perälä Finland
Nadja P. Marić Serbia
Baruch Spivak
Citations per year, relative to Baruch Spivak Baruch Spivak (= 1×) peers Nadja P. Marić

Countries citing papers authored by Baruch Spivak

Since Specialization
Citations

This map shows the geographic impact of Baruch Spivak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baruch Spivak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baruch Spivak more than expected).

Fields of papers citing papers by Baruch Spivak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baruch Spivak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baruch Spivak. The network helps show where Baruch Spivak may publish in the future.

Co-authorship network of co-authors of Baruch Spivak

This figure shows the co-authorship network connecting the top 25 collaborators of Baruch Spivak. A scholar is included among the top collaborators of Baruch Spivak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baruch Spivak. Baruch Spivak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shmulewitz, Dvora, Jacquelyn L. Meyers, Efrat Aharonovich, et al.. (2014). Alcohol consumption mediates the relationship between ADH1B and DSM-IV alcohol use disorder and criteria. PubMed Central. 3 indexed citations
3.
Stryjer, Rafael, et al.. (2012). Escitalopram in the treatment of patients with schizophrenia and obsessive–compulsive disorder. International Clinical Psychopharmacology. 28(2). 96–98. 25 indexed citations
4.
Stryjer, Rafael, et al.. (2011). Prevalence of Dementia in an Elderly illiterate Native Mexican Population of Indigenous Origin. Journal of Public Health and Epidemiology. 3(11). 556–559. 2 indexed citations
5.
Levine, Joseph, Tali Vishne, Tzvi Dwolatzky, et al.. (2007). Elevated serum homocysteine levels in male patients with PTSD. Depression and Anxiety. 25(11). E154–E157. 36 indexed citations
6.
Mozes, Tamar, et al.. (2006). An Open-Label Randomized Comparison of Olanzapine Versus Risperidone in the Treatment of Childhood-Onset Schizophrenia. Journal of Child and Adolescent Psychopharmacology. 16(4). 393–403. 43 indexed citations
7.
Spivak, Baruch, et al.. (2006). Reboxetine Versus Fluvoxamine in the Treatment of Motor Vehicle Accident-related Posttraumatic Stress Disorder. Journal of Clinical Psychopharmacology. 26(2). 152–156. 22 indexed citations
8.
9.
Mozes, Tamar, et al.. (2003). Olanzapine Treatment in Chronic Drug-Resistant Childhood-Onset Schizophrenia: An Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 13(3). 311–317. 37 indexed citations
10.
Kotler, Moshe, et al.. (2003). Sulpiride augmentation of olanzapine in the management of treatment-resistant chronic schizophrenia: evidence for improvement of mood symptomatology. International Clinical Psychopharmacology. 19(1). 23–26. 36 indexed citations
11.
12.
Maayan, Rachel, et al.. (2003). Brain neurosteroid changes after paroxetine administration in mice. European Neuropsychopharmacology. 13(5). 327–332. 22 indexed citations
13.
Reznik, Ilya, Roberto Mester, Moshe Kotler, et al.. (2000). Myotoxicity and Neurotoxicity during Clozapine Treatment. Clinical Neuropharmacology. 23(5). 276–280. 27 indexed citations
14.
Spivak, Baruch, Michael M. Segal, Neri Laufer, Roberto Mester, & Abraham Weizman. (2000). Lifetime psychiatric comorbidity rate in Israeli non-help-seeking patients with combat-related post-traumatic stress disorder. Journal of Affective Disorders. 57(1-3). 185–188. 5 indexed citations
15.
Laufer, Neri, et al.. (1999). 3H-Spiperone Binding to Lymphocytes in Neuroleptic-Naive-Schizophrenia and the Effect of Neuroleptic Treatment. Clinical Neuropharmacology. 22(2). 110–114. 1 indexed citations
16.
Spivak, Baruch, Batya Shohat, Roberto Mester, et al.. (1997). Elevated levels of serum interleukin-1β in combat-related posttraumatic stress disorder. Biological Psychiatry. 42(5). 345–348. 160 indexed citations
17.
Spivak, Baruch, et al.. (1997). Reduction of Aggressiveness and Impulsiveness during Clozapine Treatment in Chronic Neuroleptic-Resistant Schizophrenic Patients. Clinical Neuropharmacology. 20(5). 442–446. 56 indexed citations
18.
Kotler, Moshe, et al.. (1994). Psychiatric Aspects of Hyperemesis gravidarum. Psychotherapy and Psychosomatics. 61(3-4). 143–149. 20 indexed citations
19.
Spivak, Baruch, et al.. (1992). ??-Tocopherol Treatment for Tardive Dyskinesia. The Journal of Nervous and Mental Disease. 180(6). 400–401. 17 indexed citations
20.
Spivak, Baruch, et al.. (1989). A study of the complement system in psychiatric patients. Biological Psychiatry. 26(6). 640–642. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadja P. Marić Breakdown of academic impact, for papers by Roberto Mester Breakdown of academic impact, for papers by Sook-Haeng Joe Breakdown of academic impact, for papers by In‐Kwa Jung Breakdown of academic impact, for papers by Lefteris Lykouras Breakdown of academic impact, for papers by I Hui Lee Breakdown of academic impact, for papers by Olli Kampman Breakdown of academic impact, for papers by Ömer Aydemır Breakdown of academic impact, for papers by Clemente García‐Rizo Breakdown of academic impact, for papers by Jonna Perälä
Rankless by CCL
2026